ARCHIVES

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

This article is from The Cancer Letter archive.

Vol. 30 No. 17 | April 23, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

August 12, 2011

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002

NCI’s SBIR Paylines Nears Regular Grants

September 20, 1985